Download: PDF RTF XML Booklet: Review (0) Retrieve Add item
EURORDIS SGA2021 [SGA 2021] [101015599] - Operating Grant
Project abstract

The application for the Specific Grant Agreement 2021 continues the work of EURORDIS - Rare Diseases Europe as described within the Framework Partnership 2018-21.
EURORDIS key operational objectives for 2021 build on the work of the previous work around the 4 overarching objectives:
1 Consolidating the rare disease community
2 Actively engaging RD patient representatives into the effective implementation and monitoring of legislation and strategies
3. Building capacities and empowering members and volunteers
4. Sustaining human, financial and organisational resources

Start date: 01/01/2021
End date: 31/12/2021
Duration: 12 month(s)
Current status: Finalised
Programme title: 3rd Health Programme (2014-2020)
EC Contribution: € 1 074 984,00